Found 224 clinical trials
Seeking Oklahomans who have been diagnosed with chronic or unstable angina.
Seeking Oklahomans who have been diagnosed with chronic or unstable angina.
- 256 views
- 08 Nov, 2020
- 1 location
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.
- 680 views
- 23 Nov, 2020
- 1 location
The TARGET-IV NA Trial: Multicenter Randomized Assessment of the Firehawk® rapamycin TARGET eluting cobalt chromium coronary stent system –North American Trial
subjects with ischemic heart disease (NSTEMI, recent STEMI), unstable angina, and stable coronary disease), with atherosclerotic target lesion(s) in coronary arteries with visually estimated reference vessel
- 0 views
- 18 Oct, 2021
- 1 location
FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk
FOURIER - Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk
- 260 views
- 25 Mar, 2021
- 1 location
Advanced Stage Non-small Cell Lung Cancer
Advanced Stage Non-small Cell Lung Cancer
- 230 views
- 08 Nov, 2020
- 1 location
ABSORB III - Randomized Controlled Trial
ABSORB III - Randomized Controlled Trial
- 230 views
- 08 Nov, 2020
- 1 location
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
This is a multi-center, double-blind, randomized, placebo-controlled, parallel-group phase 3 clinical study to confirm the safety and efficacy of T89 in patients with stable angina pectoris
- 0 views
- 27 Jan, 2021
- 1 location
Clinical Study of Argatroban in the Treatment of Acute Progressive Ischemic Stroke
Acute ischemic stroke (AIS) has the characteristics of high morbidity, high mortality, high disability rate and high recurrence rate. Progressive cerebral infarction (PIS) is a subtype of AIS, accounting for 10% - 40%. Because of the gradual aggravation of neurological deficit symptoms, it has a higher rate of disability and …
- 0 views
- 25 Jan, 2021
- 6 locations